Bactericidal effect of photodynamic therapy, alone or in combination with mupirocin or linezolid, on Staphylococcus aureus by Pérez-Laguna, V. et al.
ORIGINAL RESEARCH
published: 31 May 2017
doi: 10.3389/fmicb.2017.01002
Frontiers in Microbiology | www.frontiersin.org 1 May 2017 | Volume 8 | Article 1002
Edited by:
Octavio Luiz Franco,
Universidade Católica de Brasília,
Brazil
Reviewed by:
Anna V. Sharikova,
University at Albany (SUNY),
United States
Valdir Carlos Colussi,
UH Seidman Case Medical Center,
United States
*Correspondence:
Vanesa Pérez-Laguna
565686@unizar.es
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Antimicrobials, Resistance and
Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 05 April 2017
Accepted: 18 May 2017
Published: 31 May 2017
Citation:
Pérez-Laguna V, Pérez-Artiaga L,
Lampaya-Pérez V, García-Luque I,
Ballesta S, Nonell S,
Paz-Cristobal MP, Gilaberte Y and
Rezusta A (2017) Bactericidal Effect of
Photodynamic Therapy, Alone or in
Combination with Mupirocin or
Linezolid, on Staphylococcus aureus.
Front. Microbiol. 8:1002.
doi: 10.3389/fmicb.2017.01002
Bactericidal Effect of Photodynamic
Therapy, Alone or in Combination
with Mupirocin or Linezolid, on
Staphylococcus aureus
Vanesa Pérez-Laguna 1, 2*, Luna Pérez-Artiaga 2, Verónica Lampaya-Pérez 2,
Isabel García-Luque 3, Sofía Ballesta 3, Santi Nonell 4, Manuel P. Paz-Cristobal 1,
Yolanda Gilaberte 1, 5 † and Antonio Rezusta 1, 2, 6 †
1 IIS Aragón, Zaragoza, Spain, 2Department of Microbiology, Hospital Universitario Miguel Servet, Zaragoza, Spain,
3Department of Microbiology, University of Sevilla, Seville, Spain, 4 Institut Químic de Sarrià, Universitat Ramon Llull,
Barcelona, Spain, 5Department of Dermatology, Hospital San Jorge, Huesca, Spain, 6Department of Microbiology,
Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain
Antibiotic treatments frequently fail due to the development of antibiotic resistance,
underscoring the need for new treatment strategies. Antimicrobial photodynamic
therapy (aPDT) could constitute an alternative therapy. In bacterial suspensions of
Staphylococcus aureus, which is commonly implicated in cutaneous and mucosal
infections, we evaluated the in vitro efficacy of aPDT, using the photosensitizing agents
rose bengal (RB) or methylene blue (MB), alone or combined with the antibiotics
mupirocin (MU) or linezolid (LN). RB or MB, at concentrations ranging from 0.03 to 10
µg/ml, were added to S. aureus ATCC 29213 suspensions containing >108 cells/ml, in
the absence or presence of MU or LN (1 or 10µg/ml). Suspensions were irradiated with
a white metal halide (λ 420–700 nm) or light-emitting diode lamp (λ 515 and λ 625 nm),
and the number of viable bacteria quantified by counting colony-forming units (CFU) on
blood agar. Addition of either antibiotic had no significant effect on the number of CFU/ml.
By contrast, RB-aPDT and MB-aPDT effectively inactivated S. aureus, as evidenced by
a 6 log10 reduction in bacterial growth. In the presence of MU or LN, the same 6 log10
reduction was observed in response to aPDT, but was achieved using significantly lower
concentrations of the photosensitizers RB or MB. In conclusion, the combination of MU
or LN and RB/MB-aPDT appears to exert a synergistic bactericidal effect against S.
aureus in vitro.
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INTRODUCTION
Microbial infections are a leading causes of mortality worldwide, largely due to the development
of multidrug resistance (Livermore, 2009). In hospitals, Staphylococcus aureus, a Gram-positive
bacteria, has become the most commonly isolated pathogen involved in serious diseases (Emori
and Gaynes, 1993), and the emergence of methicillin-resistant S. aureus (MRSA) strains worldwide
poses serious risks to patients with immunological diseases (Orrett and Land, 2006; Boucher et al.,
2009). Several antibiotics, including mupirocin (MU) and linezolid (LN), have proven effective
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against both methicillin-resistant and non-resistant strains of S.
aureus (Tallón et al., 2002; Larru et al., 2016). MU is one of the
most frequently used antibiotics for topical treatment of S. aureus
skin infections (Saderi et al., 2008), while LN is more commonly
administered intravenously (Cattaneo et al., 2013).
Although results vary depending on the studied strain and
its geographical localization, several recent studies suggest that
the antibiotic resistance of S. aureus is on the rise, underscoring
the need for new treatment strategies (Orrett, 2008; Saderi et al.,
2008; Gu et al., 2013; Gostev et al., 2015; Larru et al., 2016).
Antimicrobial photodynamic therapy (aPDT) is based on the
use of photosensitizer molecules that are activated by harmless
visible light in the presence of oxygen. This combination
generates reactive oxygen species that can oxidize many
biological molecules, including proteins, nucleic acids, and lipids,
leading to cell death (Henderson and Dougherty, 1992). Given
the rapid and selective union that forms between photosensitizers
and the cells of microorganisms, aPDT has been proposed as an
alternative treatment for localized infections (Dai et al., 2012).
Phenothiazinium derivates and fluorescein-like molecules,
such as methylene blue (MB) and rose bengal (RB), respectively,
are polycyclic aromatic molecules that have been used as
photosensitizers in aPDT, demonstrating the efficacy of this
approach in inactivating resistant forms of bacteria that are not
easily killed by conventional antibiotics. Initial in vitro studies
have produced promising results, supporting the use of these
compounds in the treatment of microbial infections (Demidova
and Hamblin, 2005; Tanaka et al., 2012). The combination aPDT
and conventional antibiotics to treat staphylococcal infections
has also shown significant potential, opening up new avenues in
the quest for novel therapies for these dangerous and recurrent
infections (Di Poto et al., 2009; Sbarra et al., 2009).
The aim of this study was to compare the in vitro efficacy
of aPDT using the photosensitizers RB or MB (RB-aPDT and
MB-aPDT), combined with the antibiotics MU or LN, against S.
aureus.
FIGURE 1 | Absorption spectra of rose bengal (left) and methylene blue (right).
MATERIALS AND METHODS
Chemicals and Media
– Solvent: Bidistilled water.
– Culture Media: Columbia blood agar (BA) (Oxoid R©; Madrid,
Spain).
– Antibiotics: Mupirocin (MU) and linezolid (LN), both from
Sigma-Aldrich R© (Madrid, Spain). Both antibiotics were
applied at concentrations of 1 µg/ml and 10 µg/ml, both of
which exceed the minimum inhibitory concentration of the
strain (EUCAST) but do not cause significant damage alone
in S. aureus strains. Respective controls were performed.
– Photosensitizers: Methylene blue (MB), purchased from
Sigma-Aldrich R© (Madrid, Spain), and (RB), from Sigma-
Aldrich-Fluka R© (Madrid, Spain). Stock MB and RB solutions
were prepared and diluted in bidistilled water immediately
prior to use. All solutions were prepared and handled under
light-restricted conditions. Concentrations ranged from 0.03
to 10 µg/ml. This concentration range was chosen based
on unpublished results from previous experiments performed
in our laboratory using 2-fold serial dilutions from 640 to
0.03µg/ml of both photosensitizers.
Light Sources
Two light-emitting diode (LED) and one white metal halide
(WMH) lamps were used.
For RB (maximum absorption λ, 557 nm) andMB (maximum
absorption λ, 665 nm) (Soria-Lozano et al., 2015; Figure 1) aPDT
was performed using LED lamps emitting at 515 ± 10 nm
(5.8 mW/cm2) and 625 nm ± 10 nm (7 mW/cm2) (Figure 2),
respectively, with fluences of 18 J/cm2 and 37 J/cm2.
For both photosensitizers a WMH lamp emitting at 420–700
nm (Soria-Lozano et al., 2015) at a fluence of 37 J/cm2 was used
(Figure 3). The lamp had an irradiance of 90 mW/cm2. The
specific irradiance values at the maximum absorption λ of RB
andMB are 292 µW/cm2 at 557 nm and 300 µW/cm2 at 665 nm,
respectively.
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FIGURE 2 | Emission spectra of LED lamps.
Microorganisms and Growth Conditions
Staphylococcus aureus ATCC 29213 was acquired from the
American Type Culture Collection (ATCC, Rockville, MD, USA).
Microorganisms were grown aerobically overnight on BA plates
at 35◦C. The inoculum was prepared in bidistilled water and
adjusted to 0.5 ± 0.03 on the McFarland scale [concentrations in
the range of >108 colony-forming units per ml (CFU/ml)]. Cell
viability was assessed in serial dilutions of suspension controls
by counting CFU after incubation overnight at 35◦C on BA. For
aPDT assays, samples were grown on BA in the same conditions
as controls.
In vitro Photodynamic Treatment of
Bacteria
Bacteria seeded on BA were cultured overnight at 35◦C, and
suspensions of the desired McFarland value (>107 CFU/ml)
were prepared in bidistilled water and deposited into 96-well
microtiter plates. Varying concentrations of the photosensitizer
(RB or MB; concentration range 0.03–10 µg/ml) were added,
in the presence or absence of MU or LN (1 µg/ml or 10
µg/ml). The final volume of each well was 100 µl. Irradiation
proceeded with no preincubation period; the suspensions were
immediately subjected to irradiation with fluences of either
18 J/cm2 or 37 J/cm2 using LED lamps and 37 J/cm2 using
the WMH lamp. Control samples were subjected to identical
treatment, in the absence or presence of the photosensitizer,
and were either kept in darkness or irradiated to evaluate the
effect of each parameter. After completing the aPDT protocol,
samples and controls were cultured on BA and incubated
overnight at 35◦C. The effectiveness of aPDT treatment was
assessed by counting the number of CFU/ml using a Flash
and Go automatic colony counter (IUL, S.A, Spain) and
comparing the results with controls. All experiments were
carried out at least 5 times. A reduction the number of
CFU/ml of 6 log10 was considered indicative of bactericidal
activity.
RESULTS
Photoinactivation of Bacteria by RB-aPDT
or MB-aPDT
aPDT effectively inactivated S. aureus ATCC 29213, resulting
in 6 log10 reduction in bacterial growth in all assays (Table 1,
Figures 4, 5).
Using MB as a photosensitizer, the concentration required for
a bactericidal effect was 0.62µg/ml at both fluences (18 J/cm2 and
37 J/cm2) with the 625-nm LED lamp (Figures 4D,E, 5D,E) and
at 37 J/cm2 with the WMH-lamp (Figures 4F, 5F).
Using RB as a photosensitizer, the concentration required
for a bactericidal effect was 0.62µg/ml for the WMH lamp
(Figures 4C, 5C), and 0.31 µg/ml for the 515-nm LED lamp, at
fluences of either 18 J/cm2 or 37 J/cm2 (Figures 4A,B, 5A,B).
Bactericidal Effect of aPDT Combined with
Classical Antibiotics
The inhibitory effect of aPDT on S. aureus was maintained in
the presence of 1 or 10µg/ml of MU or LN, as evidenced by
a 6 log10 reduction in all assays. However, by combining aPDT
with either of the two antimicrobial agents, the same reduction
in bacterial growth was achieved after decreasing photosensitizer
concentration by 50%, except in the case of the WMH-light
MB-aPDT + 1µg/ml LN, for which no change was observed
(Table 1, Figures 4, 5). The combination of 10µg/ml MU+ RB-
aPDT orMB-aPDT using theWMH light allowed for the greatest
decrease (>75%) in photosensitizer concentration (≤0.03µg/ml)
with respect to the concentration required in the absence of
antibiotic (0.62µg/ml) (Table 1, Figures 4C,F).
In general, using the same antibiotic concentrations and
irradiation conditions, an equivalent reduction in bacterial
activity was achieved using lower concentrations of RB than of
MB. There were 3 exceptions to this observation: 1µg/ml of LN
+ WMH light, and both concentrations of MU + WMH light
(Table 1).
MU, especially at the higher concentration (10µg/ml), was
more effective than LN in allowing a maximum decrease in
the concentration of RB used (0.03µg/ml), both at the lowest
fluence (18 J/cm2) with the 515-nm LED light and the highest
fluence (37 J/cm2) with the 515-nm LED light and theWMH light
(Table 1).
Toxic Effects of Photosensitizers,
Antibiotics, and Irradiation
At the range of concentrations evaluated and in the same
conditions as described for the experiments above, but keeping
the samples in darkness, neither photosensitizer reduced the
number of CFU/ml in the initial inoculum.
In the absence of photosensitizers and irradiation, the tested
concentrations of both antibiotics failed to effectively inactivate
the bacteria. A maximum reduction of 0.2 log10 was observed
for the highest concentration of both antibiotics (10µg/ml)
(Figures 4, 5).
Neither the LED lamp at 18 J/cm2 and 37 J/cm2 nor the
WMH-lamp at 37 J/cm2 significantly reduced the number of
CFU/ml (reduction of< 0.2 log10) (Figures 4, 5).
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FIGURE 3 | Relative emission curve of the white metal halide (WMH) lamp.
TABLE 1 | Range of minimum photosensitizer concentrations (µg/ml) required to reduce S. aureus growth by 6 log10.
MB 625 nm-LED-lamp MB WMH-lamp RB WMH-lamp RB 515 nm- LED-lamp
Fluence 18 J/cm2 Fluence 37 J/cm2 Fluence 37 J/cm2 Fluence 37 J/cm2 Fluence 18 J/cm2 Fluence 37 J/cm2
PS 0.62 0.62 0.62 0.62 0.31 0.31
PS+LN 1 µg/ml 0.31 0.31 0.62 0.31 0.16 0.16
PS+LN 10 µg/ml 0.31 0.31 0.31 0.31 0.07 0.07
PS+MU 1 µg/ml 0.31 0.31 0.31 0.31 0.16 0.16
PS+MU 10 µg/ml 0.31 0.16 ≤0.03 ≤0.03 0.03 0.03
LED, Light-emitting diode; LN, linezolid; MB, methylene blue; MU, mupirocin; PS, photosensitizer; RB, rose bengal; WMH: white metal halide.
The cumulative effect of antibiotic alone and irradiation
equated to a reduction in the number of CFU/ml of < 0.5 log10
(Figures 4, 5).
DISCUSSION
The present study demonstrates that the combination of MU or
LN with MB-aPDT or RB-aPDT exerts a synergistic bactericidal
effect against S. aureus in vitro. By combining antibiotic with
aPDT, the bactericidal effect produced by aPDT alone can be
achieved using a much lower photodynamic dose (i.e., lower
photosensitizer concentration or lower fluence). Our findings
suggest that results obtained with aPDT could be markedly
improved by combining this treatment modality with classical
antibiotic treatment.
The antimicrobial agents ampicillin, gentamicin, and
vancomycin have been previously shown to increase the
sensitivity of Enterococcus faecium to aPDT, using MB as
a photosensitizer (Chibebe Junior et al., 2013). Similarly,
gentamicin increases the efficacy of aPDT with 5-ALA against
S. aureus biofilms (Barra et al., 2015). The combination of
vancomycin and aPDT using cationic porphyrins is also highly
effective against S. aureus biofilms (Provenza et al., 2009).
By contrast, Tanaka and coworkers found that both LN and
vancomycin decrease the therapeutic effect of MB-aPDT in
a murine model of MRSA bacterial arthritis (Tanaka et al.,
2013). They hypothesized that in that mouse model aPDT
may stimulate antibacterial neutrophil activity, rather than
actively killing bacteria, and proposed that LN and vancomycin
may inhibit the activation of inflammatory cytokines without
eradicating the bacteria, thereby limiting the effect of aPDT.
In our study, the combination of LN and MB-aPDT or RB-
aPDT resulted in a synergistic bactericidal effect on a S. aureus in
suspension. To our knowledge, this study is the first to investigate
the effect of combining MU antibiotic treatment with aPDT, and
demonstrates that the greatest synergistic effect is obtained with
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FIGURE 4 | Photoinactivation of S. aureus using different concentrations of RB (left) or MB (right) combined with MU treatment. (A,D), Constant fluence of 18 J/cm2
with LED lamp; (B,E), constant fluence of 37 J/cm2 with LED lamp; (C,F), constant fluence of 37 J/cm2 with WMH lamp. C0, Control of inoculum (Without
photosensitizer, without antibiotic, without irradiation); C0−MU, Control of antibiotic (Without photosensitizer, with antibiotic, without irradiation); C0−MU−IRR, Control
of irradiation -added to the effect of antibiotic-(Without photosensitizer, with antibiotic, with irradiation).
MU + aPDT combination, particularly when RB is used as a
photosensitizer. Furthermore, to the best of our knowledge this
is the first study to investigate the effects of combining antibiotics
with aPDT using RB as the photosensitizer.
The effectiveness of RB-aPDT against S. aureus (Kato et al.,
2012; Nakonechny et al., 2013), including MRSA (Guo et al.,
2010), has been previously demonstrated, with green light (Guo
et al., 2010) producing a greater reduction in bacterial growth
than white light (Kato et al., 2012; Nakonechny et al., 2013).
These results are in good agreement with those of the present
study. We found that the concentration of RB required to reduce
bacterial growth by 6 log10 using the WMH light (0.6 ug/ml) was
double that required when green light was used (0.3 ug/ml). A
list of studies investigating the effect of RB-aPDT on S.aureus is
provided in Table 2.
Previous studies have demonstrated the in vitro efficacy of
MB-aPDT against both S. aureus and MRSA (Yow et al., 2011;
Kashef et al., 2012; Tanaka et al., 2012) using white light lamps
(Zeina et al., 2001; Nakonechny et al., 2013) and red LED lamps
(Yow et al., 2011; Huang et al., 2012; Kashef et al., 2012; Vecchio
et al., 2015). Although we used higher fluences and lower MB
concentrations, our findings are in good agreement with those
of previous studies, as shown in Table 3 (Yow et al., 2011; Huang
et al., 2012; Nakonechny et al., 2013; Vecchio et al., 2015).
Selecting a light source with an emission spectrum that
corresponds to the absorption spectrum of the photosensitizer
should theoretically result in greater efficacy (Calzavara-Pinton
et al., 2007). We observed efficient excitation of photosensitizers
using either a LED lamp with an appropriate emission λ for
each of the 2 photosensitizers tested, or a WHM light that
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FIGURE 5 | Photoinactivation of S. aureus with different concentrations of RB (left) or MB (right) combined with LN treatment. (A,D) Constant fluence of 18 J/cm2
with LED lamp; (B,E), constant fluence of 37 J/cm2 with LED lamp; (C,F), constant fluence of 37 J/cm2 with WMH lamp. C0, Control of inoculum (Without
photosensitizer, without antibiotic, without irradiation); C0−LN, Control of antibiotic (Without photosensitizer, with antibiotic, without irradiation); C0−LN−IRR, Control of
irradiation -added to the effect of antibiotic-(Without photosensitizer, with antibiotic, with irradiation).
TABLE 2 | Summary of studies of the in vitro efficacy of RB-aPDT on S.aureus.
References Strain Preincubation
(min)
Intensity
(mW/cm2)
Fluence
(J/cm2)
Emission
spectra λ (nm)
Concentration
RB (µM)
Media CFU /ml
initial
log10
reduction
Nakonechny et al., 2013 ATCC 25923 15–60 1.6 2.88 White 30 PBS 107 1.2
Kato et al., 2012 FDA 209P ND 25 15 White halogen 1–5 ND 3.107 3.9
Guo et al., 2010 MRSA 3 14 33 525 3 PBS 108 6
Tanaka et al., 2012 MRSA clinical 0 40 5 550 1 HBSS 108 7.5
Present study ATCC 29213 0 5.8 18–37 515 0.32 Water 107 >6
Present study ATCC 29213 0 90 37 420–700 0.64 Water 107 >6
RB, Rose bengal.
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TABLE 3 | Summary of studies of the in vitro efficacy of MB-aPDT on S. aureus.
References Strain Preincubation
(min)
Intensity
(mW/cm2)
Fluence
(J/cm2)
Emission
spectra λ (nm)
Concentration
MB (µM)
Media CFU/ml
initial
log10
reduction
Huang et al., 2012 8325-4 30 100 8 660 20 PBS 108 6
Vecchio et al., 2015 NCTC 8325 15 ND 5 660 20 PBS 108 4
Kashef et al., 2012 ATCC 25923 30 91 163.8 660 156.32 PBS 104–105 3.1
Kashef et al., 2012 MRSA 30 91 163.8 660 156.32 PBS 104–105 2.2
Yow et al., 2011 ATCC 25923 0 ND 30 600 3 PBS 108 6.5
Yow et al., 2011 MRSA clinical 0 ND 30 600 3 PBS 108 7
Tanaka et al., 2012 MRSA clinical 0 0.040 20 665 100 HBSS 108 6.5
Nakonechny et al., 2013 ATCC 25923 15 1.6 2.88 White 30 PBS 106 6
Zeina et al., 2001 Oxford 0 42 15.12 400–700 312.65 PBS 108 5.4
Our study ATCC 29213 0 7 18-37 625 7.6 water 107 6
Our study ATCC 29213 0 90 37 420–700 7.6 water 107 6
MB, Methylene blue.
covers the absorption spectra of most photosensitizers, making
aPDT easier to perform and avoiding the need to use a specific
lamp for each photosensitizer (Soria-Lozano et al., 2015). PDT
using artificial white light has been shown to be as effective
and well-tolerated as daylight photodynamic therapy (DL-PDT)
for actinic keratosis (O’Gorman et al., 2016). DL-PDT is a
new PDT modality in which the photosensitizer is activated
by sunlight rather than a lamp (Enk et al., 2015; Gilaberte
et al., 2015; Morton et al., 2015). The use of daylight makes
the PDT procedure simpler and more efficient (de Berker et al.,
2007; Wiegell et al., 2012; Vignion-Dewalle et al., 2015). The
results of our experiments using a white light lamp suggest
that cutaneous infections caused by S. aureus could be treated
using daylight-activated aPDT combined with either topical
(MU) or systemic (LI) antibiotic treatment. However, it should
be borne in mind that the present findings were obtained
following in vitro irradiation of cultured microorganisms, and
results could differ when deep tissue penetration of light is
required.
To our knowledge, this is the first study to investigate the
efficacy of several combinations of PDT and antibiotics in the
treatment of S. aureus. We found that the most efficacious
combination was RB-aPDT using green or white light, the
photosensitizer RB, and the antibiotic MU. While we did not
examine the effects of this approach in vivo or in biofilms,
the synergistic effects of aPDT combined with antibiotics
described here demonstrate that, at least in a bacterial suspension,
the concentration of photosensitizer required to achieve a
bactericidal effect is significantly lower than that required with
aPDT alone. The main advantage of this combination in terms
of clinical application would be a decreased intensity of blue
or red staining caused when the photosensitizer is applied to
the skin or mucous membranes, making the procedure more
cosmetically appealing. Whether this approach would decrease
the likelihood of developing antibiotic resistance or overcome
existing problems caused by antibiotic-resistant bacteria, as
has been proposed (Bartolomeu et al., 2016), remains to be
determined.
CONCLUSION
The combination of the antibiotics MU or LN with aPDT using
the photosensitizers RB orMB results in a synergistic bactericidal
effect on S. aureus in vitro.
Combining aPDT with concomitant classical antibiotic
treatment may produce better results than those obtained using
aPDT alone.
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